Home » Newsletters » BioWorld Asia

BioWorld Asia

March 11, 1998

View Archived Issues

Transgène Seeks FFr420M In IPOs In France, US

bi03111998c.html

Trinity Turns Loss To Revenue; Buyouts Helped Bottom Line

Center Studying Vaccines For Rheumatic Fever, Malaria

Cantab's Revenues Double; R&D Program Set To Expand

Glaxo, Thallia Teaming Up For Microalgae-Based Drugs

PPL Expresses Blood-Clotting Agent In Transgenic Sheep Milk

Chinese Study Horse Drug As Human AIDS Vaccine

Amgen Supporting Cell Therapy Laboratory In France

EU 'Closely Follows' Ethics Of Gene-Based Diagnostics

Chiroscience Spins Off DNA Analysis Subsidiary

Agen Rebuffs A$16M Takeover Move By Biotech International

EU May Lend Support To Added Worldwide Rules On Cloning

British Biotech Losses 'In Line With Plan'

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...